論文

査読有り 国際誌
2019年7月

Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation.

Bone marrow transplantation
  • Hisayuki Yokoyama
  • ,
  • Junya Kanda
  • ,
  • Shunichi Kato
  • ,
  • Eisei Kondo
  • ,
  • Yoshinobu Maeda
  • ,
  • Hiroo Saji
  • ,
  • Satoshi Takahashi
  • ,
  • Makoto Onizuka
  • ,
  • Yasushi Onishi
  • ,
  • Yukiyasu Ozawa
  • ,
  • Heiwa Kanamori
  • ,
  • Jun Ishikawa
  • ,
  • Yuju Ohno
  • ,
  • Tatsuo Ichinohe
  • ,
  • Minoko Takanashi
  • ,
  • Koji Kato
  • ,
  • Yoshiko Atsuta
  • ,
  • Yoshinobu Kanda

54
7
開始ページ
1004
終了ページ
1012
記述言語
英語
掲載種別
DOI
10.1038/s41409-018-0369-0

Although human leukocyte antigen (HLA) mismatch is often thought to be associated with a high incidence of cytomegalovirus (CMV) reactivation, it is not clear whether this process is mediated by HLA mismatch or other factors, such as acute graft-versus-host disease (aGVHD). Here we focused on cord blood transplantation (CBT) and examined the effects of HLA mismatch on the incidence of CMV reactivation while minimizing the effects of aGVHD. In a multivariate analysis considering aGVHD as a time-dependent covariate, a significant effect on the incidence of CMV reactivation was noted for HLA disparity (hazard ratio [HR]: 0.54 for 8/8 match compared with 3-allele mismatch) and development of aGVHD (HR: 1.26). Next, in an analysis excluding cases that developed aGVHD, the incidences of CMV reactivation for 8/8 match and 1-allele mismatch were low compared with those for other mismatches. These findings were supported by the multivariate analysis (HR: 0.49 for 8/8 match and 0.64 for 1-allele mismatch compared with 3-allele mismatch). Together, these results suggested that HLA mismatch was involved in CMV reactivation and was associated with high morbidity of opportunistic infection after CBT.

リンク情報
DOI
https://doi.org/10.1038/s41409-018-0369-0
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/30401965
URL
http://orcid.org/0000-0003-0995-9405

エクスポート
BibTeX RIS